Patents by Inventor Edward J. Moler, JR.

Edward J. Moler, JR. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170316153
    Abstract: A method of determining risk of diabetes is provided. In one embodiment, the method comprises: a) measuring the levels of a plurality of biomarkers in a blood samples obtained from a patient, wherein the plurality of biomarkers comprises at least five of the following biomarkers: glucose, adiponectin, CRP, IL2RA, ferritin, insulin and HbA1c; b) calculating a diabetes risk score for the patients using the levels and, optionally, patient age and/or gender. Results obtained from performing the assay on a reference population are similar or identical to those obtained using Formula I.
    Type: Application
    Filed: July 18, 2017
    Publication date: November 2, 2017
    Inventors: Michael P. McKenna, Michael Rowe, Edward J. Moler, JR., Robert W. Gerwien
  • Patent number: 9740819
    Abstract: A method of determining risk of diabetes is provided. In one embodiment, the method comprises: a) measuring the levels of a plurality of biomarkers in a blood samples obtained from a patient, wherein the plurality of biomarkers comprises at least five of the following biomarkers: glucose, adiponectin, CRP, IL2RA, ferritin, insulin and HbAIc; b) calculating a diabetes risk score for the patients using the levels and, optionally, patient age and/or gender. Results obtained from performing the assay on a reference population are similar or identical to those obtained using Formula I.
    Type: Grant
    Filed: October 28, 2010
    Date of Patent: August 22, 2017
    Assignee: TRUE HEALTH IP LLC
    Inventors: Michael P. McKenna, Michael Rowe, Edward J. Moler, Jr., Robert W. Gerwien
  • Publication number: 20120309030
    Abstract: A method of determining risk of diabetes is provided. In one embodiment, the method comprises: a) measuring the levels of a plurality of biomarkers in a blood samples obtained from a patient, wherein the plurality of biomarkers comprises at least five of the following biomarkers: glucose, adiponectin, CRP, IL2RA, ferritin, insulin and HbAIc; b) calculating a diabetes risk score for the patients using the levels and, optionally, patient age and/or gender. Results obtained from performing the assay on a reference population are similar or identical to those obtained using Formula I.
    Type: Application
    Filed: October 28, 2010
    Publication date: December 6, 2012
    Applicant: TETHYS BIOSCIENCE, INC.
    Inventors: Michael P. McKenna, Michael Rowe, Edward J. Moler, JR., Robert W. Gerwien